The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse

European Journal of Surgical Oncology

Volumn 30, Issue 3, 2004, Pages 346-351

  de la Haba, Juan ^a   Gomez A ^a   Duenas R ^b   Ribelles, N ^c   Mendez M J ^a   Serrano, R ^a   Font, P ^a   Aranda, E ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Department of Oncology ^*  (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Breast neoplasm; Prognostic factors

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THORAX RADIOGRAPHY; TUMOR VOLUME;

EID: 12144288202     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.10.006     Document Type: Article

References (19)

1. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
2. Hortobagyi GN, Smith TL, Legha SS. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1983;1:776-781.
3. Hartveit F. When, how, and why? Semin Surg Oncol 1989; 15: 126-136.
4. Tubiana-Hulin M et al. Pronostic factors clustering in breast cancer: Biology or chronology? Eur J Cancer 1995;31A: 283-284.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
6. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-200.
7. De la Haba J, et al. Study of the factors that predict the time to progression. 2000. 11th ICACT.
8. Bloom H, Richardson W, Harrier E. Natural history of untreated breast cancer (1805-1933). BMJ 1962; 2:213-217.
9. Fox M. On the diagnosis and treatment of breast cancer. JAMA 1979;241:489-495.
10. Shek L, Godophin W, Spinenelli J. Oestrogen receptors, nodes and stage as predictors of postrecurrence survival in 457 breast cancer patients. Br J Cancer 1987;56:825-829.
11. Clark GM et al. Survival from the first recurrence: Relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 1987;5:55-61.
12. Howell A et al. Steroid hormone receptors and survival after first relapse in breast cancer. Lancet 1984;1:588-591.
13. Jatoi I et al. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17(8):2334-2340.
14. Mittra I, MacRae KD. A meta-analysis of reported correlations between prognostic factors in breast cancer: Does axillary lymph node metastasis represent biology or chronology? Eur J Cancer 1991;27(12):1574-1583.
15. Mittra I. Axillary lymph node metastasis in breast cancer: prognostic indicator or lead-time bias? Eur J Cancer 1993; 29A(3):300-302.
16. Levine M et al. When is a prognostic factor useful? J Clin Oncol 1991;9:348-356.
17. Heimann R, Hellman S. Clinical progression of the breast cancer malignant behavior: What to expect and when to expect it. J Clin Oncol 2000; 18:591-599.
18. Holland PA et al. A comparison of axillary node status between cancer detected at the prevalence and first incidence breast screening round. Br J Cancer 1996;74: 1643-1646.
19. Anderson TJ et al. Comparative pathology of prevalent and incident cancer detected by breast screening. Lancet 1986; 8:519-522.